Galapagos NV header image

Galapagos NV

GLPG

Equity

ISIN BE0003818359 / Valor 2130343

Euronext - Euronext Amsterdam (2026-02-27)

EUR 28.42+0.35%

Galapagos NV
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Galapagos NV is a Belgium-based clinical-stage biotechnology company that discovers and develops small-molecule medicines primarily for inflammatory and fibrotic diseases. Using internal discovery platforms for target identification and medicinal chemistry, the company advances candidates through preclinical and clinical development and combines an in-house pipeline with strategic partnerships to support later-stage development and commercialization; a notable collaboration with Gilead Sciences has played a central role in the development and commercial strategy for several of its assets. Galapagos is publicly listed (Euronext Brussels and Nasdaq) and focuses on disease-modifying oral therapies, maintaining research operations in Europe and the United States while managing a portfolio that has seen both clinical progress and program setbacks typical of the biotech sector.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

11.5%1Y

-21.0%3Y

-58.4%5Y

Performance

31.4%1Y

29.3%3Y

33.1%5Y

Volatility

2213 M

Market cap (USD)

77,123

Daily traded volume (Shares)

26.36 / 25.88

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Alcon Inc.

Alcon Inc. Valor: 43249246

Annual Return

-50%0%+50%

Risk level

110

0.15%CHF 66.86

BACHEM HOLDING LTD

BACHEM HOLDING LTD Valor: 117649372

Annual Return

-50%0%+50%

Risk level

110

1.45%CHF 59.40

Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A. Valor: 2791431

Annual Return

-50%0%+50%

Risk level

110

-3.23%CHF 18.60

EssilorLuxottica SA

EssilorLuxottica SA Valor: 497537

Annual Return

-50%0%+50%

Risk level

110

-5.89%EUR 225.20

bioMerieux SA

bioMerieux SA Valor: 38147803

Annual Return

-50%0%+50%

Risk level

110

3.73%EUR 100.00

Siemens Healthineers AG

Siemens Healthineers AG Valor: 40652181

Annual Return

-50%0%+50%

Risk level

110

-0.59%EUR 42.14

Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA Valor: 332902

Annual Return

-50%0%+50%

Risk level

110

-0.82%EUR 50.90

Fresenius Medical Care AG

Fresenius Medical Care AG Valor: 520878

Annual Return

-50%0%+50%

Risk level

110

0.59%EUR 39.45

Evolent Health Inc

Evolent Health Inc Valor: 28153126

Annual Return

-50%0%+50%

Risk level

110

-2.11%USD 3.25

Vita 34 AG

Vita 34 AG Valor: 2333201

Annual Return

-50%0%+50%

Risk level

110

0.00%EUR 5.20

SIX

FactSet

Clearbit

Logos provided by Clearbit